Management of Gram-negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact with and without Antibiotic Stewardship
15 September 2020
Verigene Blood-Culture Gram-Negative is a rapid diagnostic test (RDT) that detects GNs and resistance within hours from Gram-stain. The majority of data supports the use of RDTs with antimicrobial stewardship (AMS) intervention in gram-positive BSI; Less is known on for GN BSI.
With the introduction of RDT and AMS, both proportion and time to optimal therapy optimal antibiotic therapy improved, especially among those with an existing ID consult. This study highlights the beneficial role of RDTs in GN BSI.
Further reading: open Forum Infectious Diseases
Author(s): Kimberly C Claeys, Emily L Heil, Stephanie Hitchcock, J Kristie Johnson, Surbhi Leekha
Healthy Patients
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
